< Return to trials

Atrial Fibrillation

Overview

Lillestol Research has several years of trial experience with the atrial fibrillation indication/diagnosis. The trials have varied in phase from the investigational product phase to observational.

Spotlight Trial(s)

  1. This was an investigational product vs. warfarin trial with the objective of preventing strokes in patients with atrial fibrillation. Lillestol Research was able to meet and exceed the sponsor’s enrollment expectation screening 15 and randomizing 11 patients in a 28-month enrollment period.
  2. This was an investigational product vs. warfarin trial with the objective of preventing strokes in patients with atrial fibrillation. Lillestol Research was able to meet and exceed the sponsor’s enrollment expectation randomizing 9 patients in a 10-month enrollment period.
  3. This was an observational trial that followed patients diagnosed with atrial fibrillation over the course of 3 years. Lillestol Research was able to meet and exceed the sponsor’s enrollment expectation randomizing 37 patients in an 11-month enrollment period. This trial serves as just one example of our site’s excellent retention rate; all 37 patients were retained for the duration of the 36-month trial.